La cadena de opciones muestra datos clave de las opciones de acciones de Organon a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Organon..

Organon (NYSE:OGN) Bolsa, Cadena de Opciones

Organon

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Organon & Co

Origin Protocol - United States Dollar

OROGEN ROYALTIES INC by Orogen Royalties Inc.

Orogen Royalties Inc

ORGANA TECHS GRP INC by Organa Technologies Group, Inc.

<p>Stifel  analyst Stephen Gengaro   maintains Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) with a Buy and raises the price target from $23 to $25.</p>


News

Price Target

Analyst Ratings

LBRT

Stifel Maintains Buy on Liberty Energy, Raises Price Target to $25

PLTR

Live On CNBC, Palantir CEO Alex Karp Says "We Are At The Way Beginning Of Our Trajectory"; "Focused Around Making Tech Have The Most Value In The Fastest Way Possible"

<p>Stifel  analyst Brian Chin   maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Buy and raises the price target from $800 to $825.</p>


KLAC

Stifel Maintains Buy on KLA, Raises Price Target to $825

Trading Ideas

BAOS

Baosheng Media Group Shares Halted On Circuit Breaker To The Upside, Stock Now Up 62.9%

<p>Stephens &amp; Co.  analyst Russell Gunther   reiterates Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) with a Equal-Weight and maintains $71 price target.</p>


Reiteration

ABCB

Stephens & Co. Reiterates Equal-Weight on Ameris, Maintains $71 Price Target

<p>Stifel  analyst Benjamin Nolan   maintains Kirby (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEX#NYSE">KEX</a>) with a Buy and lowers the price target from $136 to $135.</p>


Stifel Maintains Buy on Kirby, Lowers Price Target to $135

<p><strong>Shaquille O'Neal</strong>, the legendary NBA star, is known for his dominance on the court, his charisma, and his larger-than-life personality. But when it comes to spending money, Shaq has some wild stories. One of the craziest times was when he spent $600,000 on two Rolls Royce cars just because <strong>Mike Tyson</strong> bought three.</p>
<p>Yes, you read that right. Shaq admits that this impulsive decision wasn't about necessity or even desire. It was about <a href="https://www.benzinga.com/real-estate/25/01/43242795/mike-tyson-splurges-13-million-on-florida-mansion-after-jake-paul-defeat">keeping up with the heavyweight champ</a>. &#8220;Me and Tyson were at the Rolls-Royce dealership,&#8221; Shaq shared in an <a href="https://www.youtube.com/watch?v=Mza5tTgh9hA">interview</a> with Graham Bensinger, recalling the moment. Tyson, in true flashy fashion, decided to purchase three Rolls-Royces on the spot. And Shaq? Well, he couldn't let that slide.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"><strong> </strong><strong>you can become an investor for $0.80 per share today.</strong></a></strong></li>
<li><strong>According to Juniper Research, the total value of B2B cross-border payments stored on the blockchain is projected to exceed $4.4 trillion — <a href="https://www.benzinga.com/money/web3-enabler-future-of-enterprise-transactions"><strong>Join the first company to bring blockchain payments to Salesforce early with just $100.</strong></a></strong></li>
</ul>
<p>&#8220;I wasn't going to buy three,&#8221; Shaq confessed. &#8220;But I wasn't going to let him outdo me, either. So, I bought two.&#8221; Just like that, $600,000 vanished in a matter of moments, &#8220;down the drain.&#8221; The purchase wasn't planned, and Shaq himself later acknowledged it was pure competitiveness that drove him to match Tyson's extravagant flex.</p>
<p>This wasn't the first time Shaq spent money like that. Early in his career, he <a href="https://www.benzinga.com/personal-finance/24/10/41561800/nba-legend-shaq-says-i-spent-a-million-dollars-in-30-minutes-on-a-major-spending-spree-then-a-ba">spent $1 million in just 30 minutes</a> after getting a big paycheck. He also once tried to put a fish tank in his car speakers because he thought it would be cool. Sadly, the fish didn't survive the drive to practice, and Shaq ended up with a soggy mess instead of a cool car.</p>
<p><strong>Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>You can invest today for just $0.26/share with a $1000 minimum.</strong></a></strong></p>
<p>The Rolls-Royce story shows how young athletes can make big mistakes with money when they suddenly have so much of it. For Shaq, buying those cars wasn't really about needing them—it was about trying to prove something.</p>
<h2 class="wp-block-heading">A Lesson in Financial Growth</h2>
<p>The good news is that Shaq learned from his early spending sprees. After blowing through his first million dollars, a bank manager gave him a reality check. This made Shaq realize he needed to understand money better. Over time, he learned how to budget, invest, and make smart business decisions.&nbsp;</p>
<p><strong><em>See Also: <strong>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — </strong><a href="https://www.benzinga.com/money/masterworks"><strong>this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</strong></a></em></strong></p>
<p>Today, <a href="https://www.benzinga.com/startups/24/10/41211519/they-would-turn-away-shaq-got-an-mba-because-people-disrespected-him-he-also-paid-for-15-of-his-frie">Shaq has a doctorate</a> in organizational learning and leadership with a specialization in human resource development from Barry University and is <a href="https://www.benzinga.com/personal-finance/24/11/41869301/shaqs-got-a-500-million-fortune-but-his-kids-arent-getting-a-dime-without-earning-it-you-need-3-degrees-to-touch-daddys-cheese">worth around $500 million</a>. He&#8217;s also seen as a very smart and capable businessman.</p>
<p>Even though he laughs about it now, Shaq uses stories like the Rolls-Royce splurge as lessons. His biggest takeaway is that it's not about how much money you make but how well you manage it. Stories like this remind people how easy it is to lose control if you're not careful, even if you're rich.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Built on the trusted network of Fortune 500 companies, <a href="https://www.benzinga.com/money/web3-enabler-the-most-boring-blockchain-company-partners-with-salesforce"><strong>this blockchain company partners with Salesforce to uproot lengthy and expensive B2B transactions, and you can invest with just $100.</strong></a></strong></li>
<li><strong>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</strong></a></strong></li>
</ul>


Shaq Once Blew $600,000 On Two Rolls-Royces Because Mike Tyson Bought Three And He Didn't Want To Be Outdone By Him

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>ARM Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ARM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 31 uncommon options trades for ARM Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 45% bullish and 38%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $386,266, and 24 are calls, for a total amount of $873,758.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $80.0 to $220.0 for ARM Holdings over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for ARM Holdings options trades today is 903.04 with a total volume of 9,987.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for ARM Holdings's big money trades within a strike price range of $80.0 to $220.0 over the last 30 days.</p>
<h3>ARM Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738341931_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$24.75</td>
<td>$24.65</td>
<td>$24.65</td>
<td>$155.00</td>
<td>$98.6K</td>
<td>52</td>
<td align="right">40</td>
</tr>
<tr>
<td>ARM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$9.05</td>
<td>$8.9</td>
<td>$8.95</td>
<td>$145.00</td>
<td>$89.4K</td>
<td>905</td>
<td align="right">106</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$30.45</td>
<td>$29.8</td>
<td>$30.26</td>
<td>$155.00</td>
<td>$89.2K</td>
<td>551</td>
<td align="right">339</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$32.6</td>
<td>$30.9</td>
<td>$32.6</td>
<td>$180.00</td>
<td>$58.6K</td>
<td>695</td>
<td align="right">18</td>
</tr>
<tr>
<td>ARM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$2.9</td>
<td>$2.53</td>
<td>$2.58</td>
<td>$155.00</td>
<td>$53.0K</td>
<td>2.3K</td>
<td align="right">584</td>
</tr>
</tbody>
</table>
</p>
<h3>About ARM Holdings</h3>
<p>Arm Holdings is the IP owner and developer of the ARM architecture (ARM stands for Acorn RISC Machine), which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allows them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Off-the-shelf and architectural customers pay a royalty fee per chip shipped.</p>
<p>After a thorough review of the options trading surrounding ARM Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of ARM Holdings</h3>
<ul>
<li>Currently trading with a volume of 3,161,569, the ARM's price is up by 5.72%, now at $162.0. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 5 days.</li>
</ul>
<h3>What The Experts Say On ARM Holdings</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $152.33333333333334.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Susquehanna persists with their Neutral rating on ARM Holdings, maintaining a target price of $140.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on ARM Holdings, which currently sits at a price target of $162.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on ARM Holdings, maintaining a target price of $155. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for ARM Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Check Out What Whales Are Doing With ARM

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Rivian Automotive</strong>.</p>
<p>Looking at options history for Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) we detected 16 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 43% of the investors opened trades with bullish expectations and 56% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $210,670 and 13, calls, for a total amount of $878,088.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $25.0 for Rivian Automotive, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Rivian Automotive's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Rivian Automotive's substantial trades, within a strike price spectrum from $10.0 to $25.0 over the preceding 30 days.</p>
<h3>Rivian Automotive 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738341926_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$4.85</td>
<td>$4.75</td>
<td>$4.75</td>
<td>$10.00</td>
<td>$142.0K</td>
<td>3.0K</td>
<td>620</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.85</td>
<td>$10.00</td>
<td>$140.1K</td>
<td>3.0K</td>
<td>319</td>
</tr>
<tr>
<td>RIVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.98</td>
<td>$1.95</td>
<td>$1.95</td>
<td>$12.50</td>
<td>$114.2K</td>
<td>14.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.75</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$10.00</td>
<td>$87.3K</td>
<td>8.9K</td>
<td>237</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$2.96</td>
<td>$2.94</td>
<td>$2.94</td>
<td>$11.00</td>
<td>$86.4K</td>
<td>285</td>
<td>295</td>
</tr>
</tbody>
</table>
</p>
<h3>About Rivian Automotive</h3>
<p>Rivian Automotive Inc designs, develops, and manufactures category-defining electric vehicles and accessories. In the consumer market, the company launched the R1 platform with the first generation of consumer vehicles: the R1T, a two-row, five-passenger pickup truck, and the R1S, a three-row, seven-passenger sport utility vehicle (SUV).</p>
<p>After a thorough review of the options trading surrounding Rivian Automotive, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Rivian Automotive</h3>
<ul>
<li>With a volume of 8,685,344, the price of RIVN is up 1.88% at $12.74. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 20 days.</li>
</ul>
<h3>Professional Analyst Ratings for Rivian Automotive</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $13.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $13.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Rivian Automotive with a target price of $14.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Rivian Automotive with a target price of $14.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Rivian Automotive, targeting a price of $14.<br />
&#x2A; An analyst from Truist Securities downgraded its action to Hold with a price target of $12. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Rivian Automotive, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


RIVN

Rivian Automotive Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Interactive Brokers Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IBKR, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 8 options trades for <strong>Interactive Brokers Gr</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 62% bullish and 12%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $27,500, and 7, calls, for a total amount of $569,434.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $180.0 to $270.0 for Interactive Brokers Gr over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Interactive Brokers Gr's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Interactive Brokers Gr's substantial trades, within a strike price spectrum from $180.0 to $270.0 over the preceding 30 days.</p>
<h3>Interactive Brokers Gr Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738341921_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$27.4</td>
<td>$25.5</td>
<td>$27.47</td>
<td>$270.00</td>
<td>$219.7K</td>
<td align="right">159</td>
<td align="right">0</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$14.8</td>
<td>$13.8</td>
<td>$14.5</td>
<td>$210.00</td>
<td>$72.5K</td>
<td align="right">456</td>
<td align="right">52</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$68.9</td>
<td>$65.9</td>
<td>$67.83</td>
<td>$180.00</td>
<td>$67.8K</td>
<td align="right">305</td>
<td align="right">10</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$55.7</td>
<td>$53.1</td>
<td>$54.3</td>
<td>$180.00</td>
<td>$65.1K</td>
<td align="right">501</td>
<td align="right">12</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$29.5</td>
<td>$29.0</td>
<td>$29.0</td>
<td>$200.00</td>
<td>$58.0K</td>
<td align="right">338</td>
<td align="right">20</td>
</tr>
</tbody>
</table>
</p>
<h3>About Interactive Brokers Gr</h3>
<p>Interactive Brokers is an online brokerage that generates trading commissions (around 31% of net revenue) from facilitating trading in a wide range of products, including equity, options, futures, foreign exchange, bonds, mutual funds, and exchange-traded funds. Interactive Brokers also generates net interest income (about 64% of net revenue) from idle client cash and earns fees (about 6% of net revenue) from ancillary services. Principal trading and other miscellaneous activities are small (about 5% of net revenue). The firm derives about 70% of its net revenue from the US and 30% from international markets.</p>
<h3>Interactive Brokers Gr's Current Market Status</h3>
<ul>
<li>Trading volume stands at 374,824, with IBKR's price down by -0.14%, positioned at $218.85.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 74 days.</li>
</ul>
<h3>Professional Analyst Ratings for Interactive Brokers Gr</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $230.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Interactive Brokers Gr, targeting a price of $224.<br />
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on Interactive Brokers Gr with a target price of $220.<br />
&#x2A; An analyst from Barclays persists with their Overweight rating on Interactive Brokers Gr, maintaining a target price of $231.<br />
&#x2A; An analyst from UBS has decided to maintain their Buy rating on Interactive Brokers Gr, which currently sits at a price target of $265.<br />
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $210. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Interactive Brokers Gr options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


IBKR

Market Whales and Their Recent Bets on IBKR Options

<p>Stephens &amp; Co.  analyst Raj Kumar    maintains Cigna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) with a Overweight and lowers the price target from $410 to $380.</p>


Stephens & Co. Maintains Overweight on Cigna, Lowers Price Target to $380

<p>Stifel  analyst Ruben Roy   maintains Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Hold and lowers the price target from $25 to $21.</p>


INTC

Stifel Maintains Hold on Intel, Lowers Price Target to $21

<p>Stephens &amp; Co.  analyst Kyle Joseph   maintains Credit Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACC#NASDAQ">CACC</a>) with a Equal-Weight and raises the price target from $452 to $500.</p>


CACC

Stephens & Co. Maintains Equal-Weight on Credit Acceptance, Raises Price Target to $500

WIIM

BEPC

Brookfield Renewable shares are trading higher following Q4 financial results.

ResMed shares are trading lower. The company reported Q2 financial results.

<p>Stephens &amp; Co.  analyst Andrew Terrell   maintains First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) with a Overweight and lowers the price target from $39 to $38.</p>


FIBK

Stephens & Co. Maintains Overweight on First Interstate BancSys, Lowers Price Target to $38

<p>Stifel  analyst Jim Duffy   maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Hold and raises the price target from $181 to $185.</p>


DECK

Stifel Maintains Hold on Deckers Outdoor, Raises Price Target to $185

<p>Stephens &amp; Co.  analyst Andrew Terrell   maintains FinWise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FINW#NASDAQ">FINW</a>) with a Overweight and raises the price target from $20 to $22.</p>


FINW

Stephens & Co. Maintains Overweight on FinWise, Raises Price Target to $22

<p>Stifel  analyst Adam Borg   maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Hold and raises the price target from $190 to $220.</p>


CHKP

Stifel Maintains Hold on Check Point Software, Raises Price Target to $220

Franklin Resources shares are trading higher after the company reported better-than-expected Q1 financial results.

Organon gets expanded FDA approval for VTAMA

Goldman Sachs raised the firm's price target on Organon (OGN) to $20 from $19 and keeps a Neutral rating on the shares. The firm cites the company'...

Organon price target raised to $20 from $19 at Goldman Sachs

Organon snaps six days of winning streak

Organon & Co. (OGN) JPMorgan Annual Healthcare Conference - (Transcript)

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on Organon (OGN – Research Report), with a price target of $19.00. S...

Cautious Outlook for Organon Amidst Upcoming Launches and Future Challenges

TD Cowen analyst Michael Nedelcovych took over primary coverage of Organon (OGN) with a Hold rating and $19 price target Organon presented business...

Organon transferred with a Hold at TD Cowen

AbbVie retains Humira market share above 70%: report

Organon: A Tricky 2025 Awaits, But I'm Happy With A >7% Dividend Yield

Top 4 Immunology Stocks Poised For Growth In 2025

Organon ( ($OGN) ) just unveiled an update. On January 15, 2025, Organon & Co. announced the cessation of Susanne Fiedler's role as Chief Commercia...

Organon Announces Cessation of Chief Commercial Officer Role

ABBV

ALVO

ALVOW

AMGN

ARGX

AZNCF

BIIB

BMYMP

CGEM

CHRS

FBCG

GLAXF

IFRX

INCY

REGN

RHHBF

RHHBY

RHHVF

ROIV

SDZNY

SDZXF

SNYNF

TEVA

TEVJF

TKPHF

VTRS

Press Releases

Organon Canada Promotes Geneviève Gauthier as Executive Director, Corporate Affairs and Community Engagement and Appoints Jeffrey Malawski as Executive Director, Women's Health and Established Brands

Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024

Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)

Organon Reports Results for the Third Quarter Ended September 30, 2024

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

ROIVW

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

Axsome Therapeutics

AstraZeneca PLC - American Depositary Shares

AstraZeneca

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Intra-Cellular Therapies Inc. - Common Stock

Intra-Cellular Therapies

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Johnson & Johnson

Eli Lilly

Merck & Co

Novo Nordisk

Novartis

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pfizer

Dr. Reddy's Laboratories Ltd Common Stock

Dr Reddy's Laboratories

Royalty Pharma plc - Class A Ordinary Shares

Royalty Pharma

Sanofi

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

Comments

Organon

Organon (OGN) Opciones

Organon (NYSE:OGN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL